KRAMPERA, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 207
EU - Europa 58
AS - Asia 42
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 309
Nazione #
US - Stati Uniti d'America 207
HK - Hong Kong 28
DE - Germania 11
GB - Regno Unito 9
FI - Finlandia 8
IT - Italia 7
CN - Cina 6
PL - Polonia 6
IE - Irlanda 5
UA - Ucraina 5
VN - Vietnam 4
BE - Belgio 2
SE - Svezia 2
AT - Austria 1
CL - Cile 1
EU - Europa 1
ID - Indonesia 1
KR - Corea 1
LU - Lussemburgo 1
NL - Olanda 1
SG - Singapore 1
TR - Turchia 1
Totale 309
Città #
Chandler 38
Hong Kong 28
Fairfield 23
Seattle 16
Wilmington 13
Woodbridge 13
Ashburn 12
Cambridge 10
Princeton 10
Ann Arbor 9
Houston 9
Helsinki 8
New York 8
Jacksonville 6
Warsaw 6
Dublin 5
Settimo Torinese 5
Dong Ket 4
London 4
Beijing 3
Brussels 2
Shanghai 2
Amsterdam 1
Changsha 1
Chicago 1
Hounslow 1
Kocaeli 1
Luxembourg 1
Munich 1
Norwalk 1
San Diego 1
San Francisco 1
Seoul 1
Verona 1
Vienna 1
Wandsworth 1
Totale 248
Nome #
Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia 70
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 68
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 51
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 50
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 24
Neuronal differentiation potential of human adipose-derived mesenchymal stem cells 16
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 13
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis 9
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 9
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 6
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 6
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 3
Totale 325
Categoria #
all - tutte 3.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 7 0 3
2020/2021105 3 0 5 7 24 3 17 11 6 14 3 12
2021/202239 2 4 2 1 1 2 4 1 4 6 0 12
2022/202386 6 4 5 9 6 18 0 20 12 1 2 3
2023/202485 4 6 16 2 6 11 2 5 30 3 0 0
Totale 325